Most COVID-19 treatment guidelines currently recommend tocilizumab in combination with dexamethasone in critically ill patients who are exhibiting rapid respiratory decompensation.
Signals were broadly positive for months, but never definitive: the tocilizumab story / Cozzi-Lepri, Alessandro; Smith, Colette; Mussini, Cristina. - In: CLINICAL MICROBIOLOGY AND INFECTION. - ISSN 1198-743X. - 28:3(2022), pp. 371-374. [10.1016/j.cmi.2021.10.018]
Signals were broadly positive for months, but never definitive: the tocilizumab story
Mussini, Cristina
2022
Abstract
Most COVID-19 treatment guidelines currently recommend tocilizumab in combination with dexamethasone in critically ill patients who are exhibiting rapid respiratory decompensation.
| File | Dimensione | Formato | |
|---|---|---|---|
|
PIIS1198743X21006200.pdf
Open access
Tipologia:
VOR - Versione pubblicata dall'editore
Dimensione
240.57 kB
Formato
Adobe PDF
|
240.57 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
